TGFB1 and chronic myelogenous leukemia, BCR-ABL1 positive: Finally, we show 14 additional signatures of pathway perturbation (pathway responsive genes, PROGENy analysis) (Schubert et al., 2018) in our two cohorts and found a significant upregulation of the TGF-β pathway in the CML-derived MSCs (Figure 4E).